论文部分内容阅读
目的探讨一种安全、简便、疗效确切的良性前列腺增生症(Benignprostatehyperplasia,BPH)非手术治疗方法。方法采用WE7566型前列腺组织内消融治疗仪及自行制作的消融针引导器,对23例BPH患者经直肠前列腺组织内针刺消融治疗(Transrectalinterstitialablation,TRIA)。据前列腺增生体积确定进针数,本组平均进9针,进针深度15~20cm,每针消融时间7min,消融最高温度为95℃。对21例患者治疗后3个月、6个月分别进行了随访。结果残余尿、国际前列腺症状评分(I-PSS)、生活质量评分(QOL)分别与治疗前比较差异有极显著意义(P<001),最大尿流率(MFR)及前列腺体积治疗后6个月改善显著(P<001)。结论为治疗良性前列腺增生症提供了一种新的方法
Objective To investigate a non-surgical treatment of benign prostatic hyperplasia (BPH) that is safe, simple and effective. Methods Twenty-three patients with BPH underwent transrectal intitial translational ablation (TRIA) with WE7566 prostate tissue ablation device and self-made ablation needle guider. According to the volume of benign prostatic hyperplasia to determine the number of needles, the average group into the 9-pin, needle depth 15 ~ 2 0cm, each needle ablation time 7min, ablation temperature was 95 ℃. Twenty-one patients were followed up for 3 months and 6 months respectively. Results Residual urine, I-PSS and QOL were significantly different from those before treatment (P <001), maximum flow rate (MFR) and volume of prostate after treatment 6 months improved significantly (P <0 01). Conclusions for the treatment of benign prostatic hyperplasia provides a new method